Cargando…

Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis

Patients with rheumatoid arthritis (RA) are at increased risk of cardiovascular disease. Dyslipidemia is a known adverse effect of tocilizumab (TCZ), an anti-interleukin-6 receptor antibody used in RA treatment. We aimed to assess the effect of TCZ on lipid profile and adipokine levels in RA patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoffman, Elinoar, Rahat, Michal A., Feld, Joy, Elias, Muna, Rosner, Itzhak, Kaly, Lisa, Lavie, Idit, Gazitt, Tal, Zisman, Devy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770905/ https://www.ncbi.nlm.nih.gov/pubmed/31540528 http://dx.doi.org/10.3390/ijms20184633

Ejemplares similares

Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147
por: Zisman, Devy, et al.
Publicado: (2021)

Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients
por: Gazitt, Tal, et al.
Publicado: (2021)

Implementation of Calcium and Vitamin D Supplementation in Glucocorticosteroid-Induced Osteoporosis Prevention Guidelines—Insights from Rheumatologists
por: Gazitt, Tal, et al.
Publicado: (2023)

The role of EMMPRIN/CD147 in regulating angiogenesis in patients with psoriatic arthritis
por: Rahat, Michal A., et al.
Publicado: (2020)

Treatment persistence of biologics among patients with psoriatic arthritis
por: Haddad, Amir, et al.
Publicado: (2021)

The association between psoriatic arthritis and venous thromboembolism: a population-based cohort study
por: Gazitt, Tal, et al.
Publicado: (2022)

Tocilizumab Efficacy in a Patient with Positive Anti-CCP Chronic Lyme Arthritis
por: Hirsch, Julianna, et al.
Publicado: (2016)

Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up Study
por: Gazitt, Tal, et al.
Publicado: (2023)

Real-Life Utilization of Criteria Guidelines for Diagnosis of Cardiac Sarcoidosis (CS)
por: Gazitt, Tal, et al.
Publicado: (2023)

Effects of anti-TNF-α treatment on lipid profile in rheumatic diseases: an analytical cohort study
por: Hassan, Shadi, et al.
Publicado: (2016)

High Dimensional Analyses of Circulating Immune Cells in Psoriatic Arthritis Detects Elevated Phosphorylated STAT3
por: Macaubas, Claudia, et al.
Publicado: (2022)

Citrullination in Rheumatoid Arthritis—A Process Promoted by Neutrophil Lysis?
por: Gazitt, Tal, et al.
Publicado: (2016)

Tocilizumab, Adipokines and Severe Complications of COVID-19
por: Fioravanti, Antonella, et al.
Publicado: (2020)

Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy
por: Patel, Aarat M, et al.
Publicado: (2010)

Serum interleukin-6 in seropositive rheumatoid arthritis and response to tocilizumab: An observational study
por: Kumar, Abhishek, et al.
Publicado: (2022)

Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab
por: Furer, Victoria, et al.
Publicado: (2022)

Adipokines as Potential Biomarkers in Rheumatoid Arthritis
por: Del Prete, Annalisa, et al.
Publicado: (2014)

Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis
por: Isaacs, John D, et al.
Publicado: (2013)

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis
por: Mihara, Masahiko, et al.
Publicado: (2011)

Authors’ Reply to: Tocilizumab, Adipokines and Severe Complications of COVID-19
por: Liu, Bin, et al.
Publicado: (2020)

Tocilizumab Increases Body Weight and Serum Adipokine Levels in Patients with Rheumatoid Arthritis Independently of Their Treatment Response: a Retrospective Cohort Study
por: Choi, In Ah, et al.
Publicado: (2020)

Review of tocilizumab in the treatment of rheumatoid arthritis
por: Okuda, Yasuaki
Publicado: (2008)

Tocilizumab in the treatment of rheumatoid arthritis and beyond
por: Shetty, Anjali, et al.
Publicado: (2014)

Tocilizumab: A Review in Rheumatoid Arthritis
por: Scott, Lesley J.
Publicado: (2017)

Exploring the Role of Interleukin-6 Receptor Inhibitor Tocilizumab in Patients with Active Rheumatoid Arthritis and Periodontal Disease
por: Ancuța, Codrina, et al.
Publicado: (2021)

Comorbidities in Patients with Psoriatic Arthritis
por: Haddad, Amir, et al.
Publicado: (2017)

Adipokines in Rheumatoid Arthritis: Emerging Biomarkers and Therapeutic Targets
por: Bilski, Jan, et al.
Publicado: (2023)

Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis
por: Ogata, Atsushi, et al.
Publicado: (2012)

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
por: Pers, Yves-Marie, et al.
Publicado: (2011)

Serum Proteome Analysis in Patients with Rheumatoid Arthritis Receiving Therapy with Tocilizumab: An Anti-Interleukin-6 Receptor Antibody
por: Yanagida, Mitsuaki, et al.
Publicado: (2013)

Lupus myocarditis in an octogenarian patient—a case report
por: Shemesh, Elad, et al.
Publicado: (2020)

Treatment Persistence of Apremilast Among Patients with Psoriatic Arthritis
por: Haddad, Amir, et al.
Publicado: (2023)

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
por: Mahamid, Mahmud, et al.
Publicado: (2011)

Early intervention in the treatment of rheumatoid arthritis: focus on tocilizumab
por: Yilmaz, Sedat, et al.
Publicado: (2013)

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab
por: Rubbert-Roth, Andrea, et al.
Publicado: (2016)

Refining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous Tocilizumab
por: Negoescu, Andra F., et al.
Publicado: (2014)

Tocilizumab-Induced Dermatosis in a Patient With Rheumatoid Arthritis
por: Babkoor, Doaa, et al.
Publicado: (2022)

Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKL
por: Chatzidionysiou, Katerina, et al.
Publicado: (2021)

Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis
por: Kang, Yoon, et al.
Publicado: (2013)

Insulin resistance and levels of adipokines in patients with untreated early rheumatoid arthritis
por: Manrique-Arija, Sara, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2rmotptpalhec05hqogbn2ccjf